Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2013 Jan 24;6(2):285–294. doi: 10.1161/CIRCIMAGING.112.000119

Table 2.

Size and Zeta potential analysis of liposomal preparations

Liposome
formulation*
Effective diameter
in nm (PDI)
Zeta Potential
(mV)
Rhodamine liposomes for in
vitro optical imaging
Non-PEG – 100 108 (0.074) − 81 ± 7
Non-PEG – 200 166 (0.059) − 65 ± 2
Non-PEG – 400 270 (0.177) − 70 ± 4
PEG – 100 103 (0.073) − 36 ± 2
PEG – 200 146 (0.111) − 39 ± 2
PEG – 400 218 (0.125) − 39 ± 3
Liposomal-iodixanol for in
vitro CT imaging
Non-PEG- 100 93 (0.067) − 58 ± 3
Non-PEG – 200 144 (0.115) − 60 ± 2
Non-PEG – 400 225 (0.121) − 69 ± 2
PEG – 100 98 (0.112) − 37 ± 2
PEG – 200 119 (0.108) − 33 ± 2
PEG – 400 153 (0.071) − 33 ± 1
Liposomal-iodixanol for in
vivo studies
IV-400 172 (0.1) − 69 ± 1
*

the numbers 100, 200 and 400 indicate pore sizes of filter membranes through which the liposomes were extruded.

PDI is the poly-dispersity index of the particle sizes, defined as the ratio of the volume mean diameter to the number mean diameter.